Eli Lilly’s weight loss drug Zepbound was found to reduce obstructive sleep apnea in adults with obesity, the drugmaker said in a release Wednesday.
Related Posts
Whooping cough rising sharply in some countries. Why you may need a booster.
Whooping cough outbreaks in Europe, Asia and parts
FDA faces backlash over approval of genetic test for opioid addiction risk
The Food and Drug Administration is facing backlas